EUVIMEDEUVIMED entdecken
Crossref

Interferons dominate damage and activity in juvenile scleroderma

Hulya Kose, Abdurrahman Simsek, Muhammed Ali Kizmaz, Tugce Bozkurt, Ferdi Ozturk, Sukru Cekic, Ferah Budak, Hayriye Sarıcaoglu, Sara Sebnem Kilic iD

Modern Rheumatology · 15.10.2024 · 34 (6) · 1178-1184

DOI: 10.1093/mr/roae032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Rheumatology, online erschienen am 06.04.2024. Verfasst von Hulya Kose und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Immunology and Rheumatology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey. Hauptthemen laut MEDLINE: Scleroderma, Localized, Scleroderma, Systemic, Interferons, Cytokines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Juvenile scleroderma is a heterogeneous group of diseases associated with sclerotic skin lesions, grouped as juvenile systemic sclerosis and juvenile localized scleroderma. This study aims to measure the cytokine and chemokine levels involved in interferon (IFN) signalling in patients with juvenile scleroderma and determine their correlation with disease severity.

Methods

Twenty-nine juvenile localized scleroderma, five juvenile systemic sclerosis, and nine healthy controls were included in the study. Cytokines and chemokines involved in IFN gene signalling (IL-1, IL-6, IL-8, IP-10, MCP1, TNF-α, CXCL-11, IFN-α, IFN-β, IFN-γ) and IFN-stimulated genes (ISGs), including IFI27, IFI44, ISIG15, IFIT1, OAS1, RSAD2, were measured by ELISA and RT-PCR method, respectively.

Results

A significant increase in IFN-α, IFN-β, IFN-γ, TNF-α, IL-1, IL-6 IL-8, IP-10, and MCP1 levels was observed in patients with juvenile systemic sclerosis compared with the healthy control group. Furthermore, IFN-α and IP-10 were elevated in both juvenile localized scleroderma and juvenile systemic sclerosis compared to the healthy control group. IFN-γ and IFN-α positively correlated with LoSAI and LoSDI levels, respectively. According to PGA-A analysis, IFN-β, IFN-γ, TNF-α, IL-8, IP10, MCP1, and CXCL11 were significantly higher in active disease than in the inactive state in both groups.

Conclusion

The results suggest that IFN signalling may be impaired in patients with juvenile scleroderma. Significant changes were observed in cytokines and genes related to IFN signalling, which may have a crucial role in monitoring disease activity. In addition, we have gained important insights into the possibility of using IFN-α and IFN-γ as biomarkers for monitoring juvenile scleroderma activity and damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, LocalizedScleroderma, SystemicInterferonsCytokinesHumansMaleFemaleChildAdolescentChild, PreschoolSeverity of Illness IndexChemokines

Stichwörter der Autor:innen

Juvenile sclerodermainterferonjuvenile systemic sclerosis

Substanzen

InterferonsCytokinesChemokines

Autor:innen und Institutionen

  • Department of Pediatric Immunology and Rheumatology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
  • Department of Immunology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
  • Department of Dermatology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.

ORCID-Profile: Sara Sebnem Kilic

Zitieren

APA

Kose, H., Simsek, A., Kizmaz, M. A., Bozkurt, T., Ozturk, F., Cekic, S., Budak, F., Sarıcaoglu, H., & Kilic, S. S. (2024). Interferons dominate damage and activity in juvenile scleroderma. Modern Rheumatology, 34(6), 1178-1184. https://doi.org/10.1093/mr/roae032

Vancouver

Kose H, Simsek A, Kizmaz MA, Bozkurt T, Ozturk F, Cekic S, et al. Interferons dominate damage and activity in juvenile scleroderma. Modern Rheumatology. 2024;34(6):1178-1184. doi:10.1093/mr/roae032

BibTeX
@article{Kose2024,
  author = {Kose, Hulya and Simsek, Abdurrahman and Kizmaz, Muhammed Ali and Bozkurt, Tugce and Ozturk, Ferdi and Cekic, Sukru and Budak, Ferah and Sarıcaoglu, Hayriye and Kilic, Sara Sebnem},
  title = {Interferons dominate damage and activity in juvenile scleroderma},
  journal = {Modern Rheumatology},
  year = {2024},
  volume = {34},
  number = {6},
  pages = {1178--1184},
  doi = {10.1093/mr/roae032}
}
Kostenlos starten →